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Introduction
The eighth annual Bio-Ontologies meeting was
h e l do n2 4 th June at ISMB 2005 in Detroit.
Its principle aim over the years has been to
build a community forum that brings together
biologists and computer scientists to discuss the
development and use of ontologies within the
domain of biology. During this time, it has aimed
to stimulate discussion about the role of Ontologies
and their associated technologies for describing,
sharing, analysing and searching knowledge about
biological systems.
Ontology papers have been appearing in the
ISMB proceedings since the conference’s incep-
tion. Pioneering work by Peter Karp with Eco-
Cyc [1] demonstrated the use of ontologies as the
backbone of knowledge bases. Since the ﬁrst Bio-
Ontologies meeting in 1998, ontologies have an
increasing presence in bioinformatics; particularly
with the advent of the Gene Ontology [2] that
demonstrated the value of supplementing genomic
annotation with ontology terms. This meeting, like
its predecessors from 1998 onwards, has been dom-
inated by talks about the Gene Ontology.
This interest in ontology from the biomedical sci-
ences is intersecting with interest in bio-ontologies
and their use from the outside world in the form of
the Web community; the Semantic Web vision now
being actively promoted as the “next generation”
Web makes heavy use of ontological technology;
this, in turn, is leading to increasing provision of
mature tools and experience, lessening the acti-
vation energy for those biologists who wish to
develop or use ontologies. In the main ISMB con-
ference, the use of semantic web, or at least its
technologies, was a recurrent theme.
A recurrent issue in this year’s meeting, high-
lighted particularly by Mark Musen’s keynote,
are the attempts to move bio-ontology develop-
ment to a more industrial scale (Further infor-
mation about this talk and others mentioned in
this article are available from the Bio-Ontologies
Website). Currently, ontology development is often
carried out by small groups of individuals, mir-
roring much of biology before the advent of
community wide sequencing efforts. With the
large numbers of ontologies currently being pro-
duced (see http://obo.sourceforge.net, for exam-
ples), orthogonality, maintenance and consistency
are all becoming key issues. At the current time,
there is a relatively poor understanding of both
the best practises which are necessary and the
technology which will be required to support
these best practices; what, for instance, are the
best mechanisms for peer review of ontologies; is
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centralised management necessary as has happened
with human gene naming, or are more “free-for-
all”, decentralised approaches possible? This theme
was re-visited in the day’s panel session.
Panel session
This year we had a post-lunch panel session with
the following panelists:
• Mark Musen, Stanford University;
• Larry Hunter, University of Colorado;
• Judith Blake, Jackson Lab;
• Eric Neumann, W3C co-chair, Health-care and
Life Sciences Interest Group.
In the current context of rapidly growing activ-
ity in the bio-ontology sector and possible new
horizons in the Semantic Web, there are many con-
tentious issues facing our community. With this in
mind, we gave the panelists the following questions
with which to focus discussion:
1. We should be more authoritarian and less liberal
in the building of Bio-Medical Ontologies.
Background:
As the development of bio-medical ontologies
has become more widespread, the development
of multiple ontologies with overlapping terms is
inevitable (and is, to some extent, already happen-
ing).
Currently, a very “free market” approach is
being followed. Is this a strength? Or should it be
replaced with something more centralised, similar
to, for example, the Human Gene Nomenclature
Committee.
2. We are better at developing Bio-Medical Ontolo-
gies than we are at using them.
Background:
Bio-Medical ontologies now have a broad spread
over the subject area. The main use of these
ontologies is to annotate records which we then
retrieve by query or navigation. Should we be doing
more with these ontologies? Even this narrow use
lacks good user facing and reusable tooling.
3. The future for Bio-Medical ontologies is to be
the semantic infrastructure for the computation-
ally enabled systems biology view of life.
Background:
In the Semantic Web vision, data and services
are described semantically, such that they become
computationally amenable. Bioinformatics is in a
strong position to realise this vision, which might
affect both the way the world uses data, and the
way biologists view life. Is this either possible, or
desirable, or both?
In the 90 minutes for the panel session, we
only managed to cover the ﬁrst question. In all
likelihood, this is due to the pertinence of the
question. As a community, we now have a great
number of ontologies available. As ontologies are
meant to enable a shared understanding of a
domain, it would be good if we did not have
conﬂicting ontologies, but did have a common
style, etc. Should such an effort be policed? By and
large, there was a consensus on the panel and in
the audience–that some kind of monitoring was in
order. Larry Hunter, in rejecting authoritarianism,
invoked government by the people for the people.
In the best libral tradition, it was felt that control
is needed but openness and feedback from users
was the best way to gain control. This discussion
was particularly interesting in the light of the new
National Center for Biomedical Ontology [3].
Research talks
All of the abstracts for these talks and the posters
may be found at http://bio-ontologies.man.ac.uk.
Many of the research talks also touched on the
techniques of the Semantic Web. Several peo-
ple discussed applications of automated reasoning
techniques: to enable complex querying over data
from the yeast community (Baker et al.) or toward
the automation of protein classiﬁcation as part of
the process of genome annotation (Wolstencroft
et al.). Ontologies are increasingly being used sta-
tistically, often to increase understanding of experi-
mental results–in the case of Vailaya et al. this was
microarray data.
Broadening this theme a little, we also had a talk
from Daniel McShan about using an ontology that
described the features by which a member of a class
of organic molecules, such as alcohols or amino
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acids, would be recognised. Such an ontology,
when given a concrete chemical could classify that
chemical. Olivier Bodenreider presented a paper
by Francisco Azuaje et al. on the use of similarity
measures working over ontologies as a method of
assigning function.
One of the best aspects of the meeting is
that every year the audience can ﬁnd out about
new ontologies and new developments in exist-
ing ontologies. One of these was a talk by Jun
Liu about developing a provenance ontology for
biological images. This complements other activ-
ities in this area, such as controlled vocabularies
for evidence as seen for GO annotations [4]. Sev-
eral more ontologies were presented in the poster
session. Finally, Olivier Bodenrider presented his
second talk on generating the implied relationships
between the Gene Ontology and other ontologies,
such as those for chemicals. This “enrichment” of
an ontology formed a good link to the next series
of talks about ontology development.
Several talks described new techniques for onto-
logical engineering; new logics better able to
describe changes in biological systems over time
(Ramakrishnan et al.) or more formal treatment
of pathological anatomical features (Smith et al.).
This year, Bio-Ontologies was also able to hold
a well attended poster session. Several of these
described new warehousing environments (Dewey
et al.; Karp et al.) or tools (Stephens et al.; Zheng
et al.). Finally, a number of posters described exist-
ing projects from several view points (Cary and
Luciano; Harris; Whetzel et al.).
Future plans
One of the surprises about Bio-Ontologies 2005
was the increase in the number of paper submis-
sions, to around 30. We were lucky to be able to
accommodate much excellent work with the late
introduction of a poster session. Given this, for
next year, we hope to modify the publication pro-
cess–we would like authors to have more space to
explain their science than we have currently been
able to provide.
We are currently investigating ways of inter-
acting better with other SIGs. The programme
at ISMB is now very full, with many different
SIGs providing excellent science, but with con-
ﬂicting schedules. For 2006, we are investigating
co-ordinating with BioLink; the synergy between
ontological representation and natural language
techniques is a natural one. This should ensure
that attendees can get maximal beneﬁt from both
programmes. We welcome any input via the bio-
ont-sig@cs.man.ac.uk email
Originally, the main use of ontologies within
biology was to enable a de facto integration
between different data sources, by providing a com-
mon vocabulary. It is clear, now, that there are
many uses beyond this. The use of ontologies is
becoming common place in data analysis, model
building and data validation. It is also clear from
this years Bio-Ontologies meeting that bio-Medical
scientists are no longer just using ontological tech-
nologies; they are contributing to their advance.
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